Factors associated with severe manifestations of histoplasmosis in AIDS

Citation
Lj. Wheat et al., Factors associated with severe manifestations of histoplasmosis in AIDS, CLIN INF D, 30(6), 2000, pp. 877-881
Citations number
7
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL INFECTIOUS DISEASES
ISSN journal
10584838 → ACNP
Volume
30
Issue
6
Year of publication
2000
Pages
877 - 881
Database
ISI
SICI code
1058-4838(200006)30:6<877:FAWSMO>2.0.ZU;2-5
Abstract
We report factors associated with severe manifestations of histoplasmosis ( such as shock, respiratory failure, and death) in patients with AIDS during an outbreak. Severe disease was present in 28 of 155 patients (17.9%). The following factors were associated with severe disease: black race (odds ra tio [OR], 2.8; 95% confidence interval [CT], 1.2-6.2); hemoglobin lever <9. 5 g/dL (OR, 2.7; 95% CI, 1.2-6.4), partial thromboplastin time >45 s (OR, 3 .1; 95% CI, 1.1-9.3); alkaline phosphatase level >2.5 times normal (OR, 3.4 ; 95% CI, 1.3-8.7); aspartate aminotransferase level >2.5 times normal (OR, 4.2; 95% CI, 1.7-10.0); bilirubin level concentration >1.5 mg/dL (OR, 9.2; 95% CI, 2.5-34.3); creatinine concentration >2.1 mg/dL (OR, 8.3; 95% CI, 2 .2-31.9); and albumin concentration <3.5 g/dL (OR, 4.6; 95% CI, 1.3-16.4). Zidovudine use was associated with decreased risk of severe disease (OR, 0. 3; 95% CI, 0.1-0.7). Multivariate analysis showed that a creatinine value > 2.1 mg/dL (OR, 9.5; 95% CI, 1.7-52) and an albumin value <3.5 g/dL (OR, 4.8 ; 95% CI, 1.0-22) were associated with an increased risk of severe disease, and zidovudine therapy remained associated with a decreased risk (OR, 0.2; 95% CI, 0.1-0.6). Findings associated with severe histoplasmosis should be recognized early and the cases managed aggressively.